Control of cardiovascular disease risk factors among patients with type II diabetes in a primary-care setting in Beijing

J Am Soc Hypertens. 2018 Feb;12(2):128-134. doi: 10.1016/j.jash.2017.12.006. Epub 2017 Dec 13.

Abstract

The aim of this study was to assess the control of blood glucose, blood pressure (BP), serum low-density lipoprotein cholesterol (LDL-c), and other cardiovascular disease risk factors among patients with type II diabetes in a primary-care setting in Beijing. We performed a cross-sectional, multi-center survey of 4056 patients with type II diabetes aged ≥40 years. In total, 22.6% were current smokers, 10.8% often drank alcohol, 29.0% were obese, and 67.4% participated in adequate levels of physical activity. About 70% of patients reported comorbid hypertension or dyslipidemia. Of these, 70.8% were being treated for diabetes and 79.3% for hypertension; 20.5% were receiving statins and 28.5% aspirin. The proportions of patients achieving their therapeutic target were 52.6% for fasting plasma glucose, 58.2% for BP, and 33.0% for LDL-c. Only 11.1% achieved all three goals. Among 1960 (48.3%) patients with a record of hemoglobin A1C, 27.8% achieved the hemoglobin A1C target (<6.5%). These data suggest that blood glucose and BP were more likely to be well controlled than LDL-c, the likelihood of control of multiple risk factors is low, and that the statin and aspirin use should be intensified in patients with a substantial risk of cardiovascular disease.

Keywords: Cardiovascular disease; control rate; diabetes; risk factor.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aspirin / administration & dosage
  • Beijing / epidemiology
  • Blood Glucose
  • Cholesterol, LDL / blood
  • Cross-Sectional Studies
  • Diabetes Complications / epidemiology*
  • Diabetes Complications / etiology
  • Diabetes Complications / prevention & control
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Dyslipidemias / blood
  • Dyslipidemias / epidemiology*
  • Dyslipidemias / etiology
  • Dyslipidemias / prevention & control
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypertension / blood
  • Hypertension / epidemiology*
  • Hypertension / etiology
  • Hypertension / prevention & control
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care / statistics & numerical data
  • Primary Health Care / methods
  • Primary Health Care / statistics & numerical data*
  • Risk Factors

Substances

  • Blood Glucose
  • Cholesterol, LDL
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human
  • Aspirin